Meningioma recurrence: The efficacy and cost-effectiveness of current screening

British Journal of Neurosurgery

Volumn 24, Issue 1, 2010, Pages 55-61

  Halliday, Jane ^a   Fernandes, Helen ^b  

^a NHS LOTHIAN   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Audit; Cost and time effectiveness; Meningioma; Post operative scanning

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE CARE; PRIORITY JOURNAL; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL AUDIT; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77149137136     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688690903431813     Document Type: Article

References (18)

1. Longstreth Jr. WT, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD. Epidemiology of intracranial meningioma. Cancer 1993;72:639-48.
2. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM. Epidemiology of intracranial meningioma. Neurosurgery 2005;57:1088-95; discussion 1088-95.
3. Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 1996;29:197-205.
4. Rausing A, Ybo W, Stenflo J. Intracranial meningioma - a population study of ten years. Acta Neurol Scand 1970;46: 102-10.
5. Huang H, Buhl R, Hugo HH, Mehdorn HM. Clinical and histological features of multiple meningiomas compared with solitary meningiomas. Neurol Res 2005;27:324-32.
6. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109.
7. Talback M, Stenbeck M, Rosen M. Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data. Eur J Cancer 2004;40: 1361-72.
8. McCutcheon IE. The biology of meningiomas. J Neurooncol 1996;29:207-16.
9. Marcus HJ, Price SJ, Wilby M, Santarius T, Kirollos RW. Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine? Br J Neurosurg 2008;22:520-8.
10. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20: 22-39.
11. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985; 62:18-24.
12. Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, Shaw EG. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 1998;73:936-42.
13. Field A. Logistic Regression, 2nd ed. Thousand Oaks, CA, Sage Publications; 2005.
14. Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet 2004;363:1535-43.
15. Naumann M, Meixensberger J. Factors influencing meningioma recurrence rate. Acta Neurochir (Wien) 1990;107:108-11.
16. Marks SM, Whitwell HL, Lye RH. Recurrence of meningiomas after operation. Surg Neurol 1986;25:436-40.
17. Adegbite AB, Khan MI, Paine KW, Tan LK. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 1983:58:51-6.
18. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. Br Med J 1996;312:71-2.